INSM
Insmed Incorporated
Stock
$111.12+2.53 (+2.33%)Close Oct 2, 2026
- Capital expenditures, 2025
- $33M
- YoY, 2025
- +48.5%
- 5-year CAGR
- +39.2%
- 10-year CAGR
- +25.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $33M | +48.5% |
| 2024 | $22M | +65.0% |
| 2023 | $13M | +34.5% |
| 2022 | $9.9M | +35.5% |
| 2021 | $7.3M | +16.8% |
| 2020 | $6.2M | −85.2% |
| 2019 | $42M | +222.9% |
| 2018 | $13M | +336.2% |
| 2017 | $3.0M | −28.5% |
| 2016 | $4.2M | +21.6% |
| 2015 | $3.5M | −35.5% |
| 2014 | $5.4M | +547.8% |
| 2013 | $826K | +184.8% |
| 2012 | $290K | −70.4% |
| 2011 | $979K | — |
| 2010 | $0 | — |
| 2009 | $0 | — |